PolandPoland

Big strides in biosimilar mAbs

07.03.2012

Polish antibody development and manufacturing specialist Mabion S.A. more than tripled its revenues in 2011 (€2.5m) compared to 2010 (€0.74m). The increase in turnover mainly resulted from stronger client demand for R&D services when applying Mabion’s technologies for manufacturing biosimilar antibody drugs, according to the firm’s CEO Maciej Wieczorek. Mabion currently runs three undisclosed biosimilar monoclonal antibody (mAb) development programmes for clients and four in-house programmes. After the Polish biotech received permission to manufacture medicinal products for clinical trials from the country’s main pharmaceutical inspecting body in December, it began preparing for clinical testing of its lead candidate Mabion­CD20, which has been developed in-house with the help of a €10m EU fund granted through the Polish Agency of Enterprise Development. Mabion and the CRO Kiecana Clinical Research are now preparing a clinical trial that will compare Mabion­CD20’s pharmaco­kinetics and pharmaco­dynamics to Roche’s originator product rituximab. The company hopes to file for EU approval for the substance in 2013.
The firm’s second programme Mabion­HER2, a copycat mAb for treating breast cancer, is still in the analytical method development phase and in vitro testing to confirm biosimilarity. Mabion

EGFR against colorectal, head and neck cancer, and MabionVEGF, a medicine for lung, breast, colorectal and kidney cancer have both entered the stage of cell development, according to Wieczorek.

PolandPoland

21.02.2009

Kraków – According to a report from Kraków-based PMR Ltd, the Czech Republic and Poland are on top in eastern Europe when it comes to outsourcing clinical trials and contract manufacture. The market analysis outlines 160...

PolandPoland

21.02.2009

Szczecin – The West-Pomeranian Center for Advanced Technologies and the German regional cluster BioCon Valley are setting up a German-Polish contact point for the life sciences. The long-term goal of the cooperation, which will...

PolandPoland

21.02.2009

Raszyn Rybie – Polish Euroimplant S.A. has received a66,000 in funding from the National Center for Research and Development (NCBiR) for product development, according to CE.biotech.com. The specialist firm for tissue...

PolandPoland

21.02.2009

Warsaw – Polish insulin and antibiotics maker Bioton S.A. has shuffled its mana­gement board after announcing that an expected deal failed to materialise. In mid-January, after Prokom Investments (Gdynia) proved unable to sell...

PolandPoland

21.02.2009

Kraków – BioCentrum Sp. zo.o. is expanding contract research activities for the bio-pharmaceutical industry. In December, the Polish specialist for preclinical ADME, cell-based assays, protein characterisation, antibody, enzyme...

PolandPoland

23.01.2009

Warsaw – Polish insulin and antibiotics maker Bioton S.A. has shuffled its management board after a failed deal hit the news. When Prokom Investments (Gdynia) failed to sell a 33.3% stake in Bioton to Jerzy Starak’s Polpharma for...

PolandPoland

11.11.2008

Warsaw – In August, the lower chamber of the Polish parliament approved a 31m EUR programme for the protection of mental health to run from 2009-2013. The programme, which is to be financed from the state budget and EU funds,...

PolandPoland

18.08.2008

Portoroz – Around 120 international bioprocessing experts met at the 3rd Monolith Summer Symposium at Portoroz to discuss how monolith chromatography can eliminate current bottlenecks in downstream processing of biological drugs....

PolandPoland

20.05.2008

Krakow – Selvita Sp. z o.o., a newly founded service provider to the biotechnological and pharmaceutical industries, has taken over biotech tools and services supplier BioCentrum Ltd. At the end of March, Selvita acquired 64% of...

PolandPoland

20.05.2008

Warsaw – Together with the top ten Polish universities, one hundred Polish technology companies have kicked-off a business chamber for advanced technology (PIGZT). The chamber will provide a platform for improving information...

Displaying results 31 to 40 out of 108

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-poland/browse/3/article/big-strides-in-biosimilar-mabs.html

Product of the week

Products

Events

All Events

Current issue

All issues